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Abstract 
The potential health effects of cocoa flavanols are well described. Ranging from reducing 
risk of developing type 2 diabetes and cardiovascular disease at population levels, moderating 
disease risk factors including endothelial function and lipid metabolism in clinical trials and 
mechanistic studies in laboratory studies highlighting target tissues and pathways. However, 
translating these benefits into public health messages is problematic, due to the high energy 
and sugar content of many cocoa products, including chocolate. This review considered the 
role of sugar in cocoa products, what are its physiological effects on bioavailability and 
bioactivity? Considering, then how cocoa products can be reformulated to reduce sugar 
intake, and the likely effects on beneficial effects of cocoa flavanols and consumer 
preferences. Ultimately, although interesting physiological effects are seen with cocoa 
flavanols, their use as a disease-modifying commodities may be limited the effect such 
products may have within an individual’s and populations overall dietary patterns.  
 
 
 
Key Words: 
Polyphenols, Cocoa, Sugar, Bioavailability, Reformulation, Prebiotics 
 
  
Introduction 
There is a considerable emerging interest over the past two decades around the potential role 
of cocoa in enhancing human health. This has a deep routed history, with cocoa having 
cultural along with a role in traditional medicine dating back to the Aztecs and Mayans in 
Central America. Historical benefits include an association with increased endurance, with 
the Codex of the time recording that Emperor Montezuma II claimed that a soldier could 
march for a whole day on a single cup of cocoa (Dillinger et al., 2000, Mellor and 
Naumovski, 2016, Ellam and Williamson, 2013).  
 
However, the historically cocoa was not consumed sweetened or processed as it is today and 
as these claims of soldier’s endurance could not be ascribed to its sugar content. Modern 
cocoa drinks and chocolate developed alongside the industrialisation of food sector in the 19th 
and 20th century. Historically, cocoa was consumed as a bitter, unstable grit containing drink, 
initially as a part of the religious ritual of the the elite of Aztec society well before its arrival 
in the chocolate houses of Europe of the 17th and 18th centuries. At the time, rapid advances 
in food technology, including the development of dried milk and effective ways to separate 
cocoa butter from cocoa solids before recombining to form a stable solid end product have 
allowed modern chocolate to be developed. These innovations occurred at the same time as 
sugar becoming more widely available, allowing for the sweet, smooth and melt in the mouth 
chocolate products that are familiar to consumers today (Dillinger et al., 2000).  
 
In order to critically considering the potential effects of adding sugar to cocoa in products, it 
is vital to consider the end form the product will take; primarily if it is a solid (chocolate) or 
liquid product (beverage). Main reason for this is that manufacturing process requires a 
consideration of a number of different variables in the development and formulation of the 
required products. The way in which the cocoa itself if process will impact on its polyphenol 
content, even before it is being incorporated into a product (Bordiga et al., 2015). This is 
before considering the potentially, large variations in bioavailability and bioactivity between 
solubilised cocoa or chocolate as delivery vehicles for cocoa flavanols (Mellor, 2013, 
Davison and Howe, 2017). Beyond their food chemistry, there are nutritional considerations 
linked to the high energy content of cocoa and chocolate products, including significant 
levels of fat (especially saturated fatty acids) and sugar, which could have the potential to 
reverse any advantageous effects of the cocoa flavanols. Attempts have been undertaken to 
replace sugar with sweeteners such as stevia (Azevedo et al., 2017), add fibre to reduce the 
overall energy content of the product (Aidoo et al., 2017) or even both approaches (Rezende 
et al., 2015) however the effect of these approaches on the bioactive effects of chocolate is 
largely unknown. Although these points are potentially academic as the quality of the 
research data counts for nothing, if the resultant food product is unpalatable to the consumer. 
During the formulation or use of any functional food product (in this case cocoa products) the 
commercial goal of the product development is to devise a method of delivery for ‘active’ 
ingredients to the maximal absorption site of the gastrointestinal tract. Therefore, it is 
empirical to consider the bioavailability and biological activity of the cocoa flavanols and 
how this may relate to the food product formulation and vice versa, before finally considering 
the place of the product in the context of whole diet patterns from a public health perspective. 
 
One challenge is the relatively poor bioavailability of cocoa flavanols, even epicatechin 
which is reported to have the best bioavailability still is has limited absorption of around 25% 
(Baba et al., 2000). This has led to questions being raised about the effect of cocoa and 
chocolate as a functional food (Rein et al. 2013), this is despite the large number of clinical 
trials supporting a beneficial effect (Mellor and Georgouspoulou, 2017). It is plausible to 
consider that even with optimal product formulation the net amount of epicatechin available 
and any effect it might product could be negated by the negative nutritional impact of the 
energy, fat and sugar content of the end product. 
 
Modern cocoa and chocolate products being highly palatable and energy dense, leads to its 
consumption being at controversy with public health messages. It appears that the potential of 
cocoa flavanols to enhance health are at odds with its high sugar and fat content resulting in a 
product with a high energy density that is desirable and easily over-consumed. Despite this, a 
growing body of data has emerged suggesting that cocoa and chocolate consumption may be 
associated with lower risk or chronic disease, especially cardiovascular disease and its 
associated risk factors (Ried et al., 2017, Larsson et al., 2016, Yuan et al., 2017). With these 
potential conflicting interests of high energy content and public health concerns about sugar, 
it is important to consider the role of sugar and other carbohydrates in cocoa and chocolate 
products and what effects might be expected if formulation changes are made to products, 
both with respect to consumer’s preferences and perceptions as well as influences on 
bioavailability and bioactivity. 
 
Mechanisms of Cocoa Flavanols: Potential interaction with sugar 
 
A number of mechanisms have been proposed in attempt to explain how cocoa flavanols may 
improve human health. Perhaps the most pertinent mechanisms explaining how cocoa 
flavanols may reduce blood pressure and reduce risk of chronic disease, is via its effect on 
nitric oxide (NO) (Fraga et al., 2011). With cocoa flavanols, having potential to induce 
endothelial nitric oxide synthase (eNOS) and therefore increase the available pool of NO, 
with additional influences of insulin mediated pathways being another potential mechanism 
(Grassi et al., 2005).  It is thought that the sugar content of chocolate could potentially negate 
any impact of the cocoa flavanols. The potential mechanism for this is seen via the depletion 
of the pool of available NO which is not a direct action of sugar, but rather the result of its 
potential to increase insulin levels, as the resulting hyperinsulinaemia could deplete the NO 
pool (Dworakowski et al., 2008, Munzel et al., 2008). This may be of importance as the 
effects of NO depletion and endothelial function are implicated in obesity and related 
metabolic diseases including type 2 diabetes and cardiovascular disease (Sansbury and Hill, 
2014).  
 
Health Policy and the Drive to Reduce Sugar Content of Foods  
Although, sugar in cocoa and chocolate products may negate the effect of cocoa flavanols, it 
is a nutrient of wider concern from a public health perspective. Relatively recently, there has 
been increased public health and political interest on the impact of sugar consumption on 
human health. Following systematic reviews showing a link between consumption of free 
sugar and obesity (Te Morenga et al., 2014) and further evidence of its negative effects on 
dental health (Moynihan and Kelly, 2014), the World Health Organisation  (World Health 
Organization., 2015) adjusted its recommendation to an absolute maximum of 10% of total 
energy from free sugar, with an aim to reduce intake to 5% of total energy coming from free 
sugars. The term ‘Free sugar’ is a recently added definition used to cover all sugars added to 
foods as well as that found in fruit juices and smoothies (World Health Organization., 2015). 
This view to recommend a more aggressive reduction in free sugar intake has been taken 
further in the UK with the Scientific Advisory Committee on Nutrition (SACN) which set the 
upper limit of 5% of total energy from free sugars for the UK population (Scientific Advisory 
Committee on Nutrition., 2015). The rationale for this stricter target is the evidence linking 
free sugar intake to obesity, with the lower intake level being justified as it could be 
associated with a 100kcal/day (418kJ/day) decrease in energy intake, that could at a 
population level reduce average Body Mass Index (BMI), and moderate population obesity 
levels. However, SACN suggested this energy reduction from sugar could be replaced with 
wholegrain, so not reducing overall energy intake and therefore not likely to impact 
population obesity levels (Scientific Advisory Committee on Nutrition., 2015). The 
relationship between free sugar intake and other diseases is emerging including associations 
with type 2 diabetes (Basu et al., 2013) and other chronic disease (Yang et al., 2014) 
however, this evidence was deemed not strong enough to inform current guidelines 
(Scientific Advisory Committee on Nutrition., 2015, World Health Organization., 2015).  
 
The increasing evidence regarding the negative implications of free sugar on human health, 
particularly related to sugar sweetened beverages, which would include based cocoa drinks 
has also led to legal changes to bring in taxation on sugar in drinks in countries as diverse as 
Mexico, France and the UK. This has led to further calls from public health, political and 
clinician groups to implement sugar taxes along with debates about the associated challenges 
in other countries including Australia.  With cocoa products however, these legislations could 
further complicate the markets potentially leading to cocoa drinks being taxed and chocolate 
not being subject to any additional levies, highlighting the challenges of health related 
taxation being applied to food and beverage products. In addition to taxation, in the UK a 
long term strategy of voluntary reformulation by the food industry which has reduced energy 
intake along with amounts of fat, sugar and salt. Together these changes potentially impact 
on cocoa and chocolate products and their development. Sugar has key roles in chocolate and 
cocoa products including flavour, a key aspect being the masking of the bitter flavours and 
clawing mouth feel  associated with the flavanols in these products (Thamke et al., 2009). 
The move to reduce energy and fat too has added pressure to reduce serving size, which in 
turn has the effect of making a product with an effective ‘dose’ of flavanols increasingly 
challenging. 
  It is therefore vital to understand the characteristics of the optimal formulation of cocoa and 
chocolate products with respect to sugar content and sweetness when delivering flavanols to 
maximise bioavailability and bioactivity. If food products are to be developed, it is key to 
devise formulations of food products aimed at optimising health whilst minimising any 
potential adverse effects. This approach is following the norms (and standards) of the 
pharmaceutical industry where the central theme is balance of benefit over potential harm.  
However, functional foods, tend to be judged primarily for hygiene, safety and contribution 
to nutritional adequacy of diets, and as such are not subject to such critical analysis. It is 
important to note, that adding a new active ingredient in the particular food product, does not 
and should not lead to it being classified automatically as a functional food. The new 
ingredients can form very complex ‘interactions’ and ‘degradations’ within the food matrices 
and as such be potentially completely inactive. 
 
Effect of Sugar on Absorption and Metabolism 
The absorption and metabolism of polyphenols and flavanols is very complex cascade of 
events that is tightly regulated by changes in pH, gut microbiota and overall health status of 
the gastrointestinal tract (Crozier et al., 2009). In foods these compounds exist as monomeric 
catechins (mainly epicatechins) and oligomeric flavanols, typically varying from dimers to 
decamers. In cocoa the ratio of these compounds depends on a range of factors; from the 
country of origin through to the method of processing (mainly fermentation and roasting) 
(Hurst et al., 2011). Typically, 34-37% of the flavanols in cocoa are monomeric and as such 
have a greater potential to be more bioavailable (Langer et al., 2011, Wollgast and Anklam, 
2000). The stability of these compounds in post-harvest foods is also an important 
consideration. In chocolate and cocoa the flavanols (especially flavano-3-ol) content has been 
reported as being stable for at least two years (Hurst et al., 2009), whereas in beverages 
stability of the product is significantly shorter, partly related to high water activity, risk of 
spoilage and their oxidative stability. Therefore, the potential increased stability of the 
flavanols in chocolate may be at least in part related to its composition including its sugar 
content, which contributes to its low water activity.  Consequently,  chocolate was described 
as an ideal matrix for the preservation and potentially the delivery of flavanols (McShea et 
al., 2008). Nevertheless, these delivery property is largely dependant on the other 
components of the chocolate formulation.  
Effects of Sugar in the Upper Gastrointestinal Tract  
To date; the effect of food ingredients other than cocoa has concentrated on the effects on the 
effect of adding milk to either beverages or solid chocolate.  The rationale for this was related 
to the effect of the milk proteins binding to flavanols and the hypothesised reduction in their 
bioavailability with studies providing less definitive information  (Roura et al., 2007, 
Rashidinejad et al., 2017). Additionally, the primary focus on the protein component of the 
milk has potentially overlooked any effect of other components including fat and lactose.  
 
 The beneficial effects in humans of cocoa flavanols in chocolate or beverages were 
suggested to be reduced due to the sugar content (Faridi et al., 2008, Njike et al., 2011).  
Typically, the added sugar in cocoa and chocolate products is sucrose, which along with 
other carbohydrate content may be of interest with respect to how it may influence 
bioavailability. In human clinical trials where cocoa was administered with or without sugar 
(sucrose), it appears that sucrose might actually enhance the flavanols absorption (Schramm 
et al., 2003). The same group continued this work to investigate the effects of other 
carbohydrate-rich foods with cocoa, which produced a similar enhancing effect on flavanols 
absorption. Although this was not necessary a representative of how it is typically consumed 
as bread and sugar were included as part of a meal containing cocoa, rather than formulated 
in a real food matrix of a typical of a chocolate or cocoa product. In addition, different types 
of sugars are not compared using a standardised flavanol intake.  
 
A review of how a range of individual macronutrients effects generally on polyphenol 
bioavailability and action was undertaken by (Jakobek, 2015). This highlighted that there 
were a number of factors of how carbohydrates may influence polyphenol and potentially 
cocoa flavanol bioavailability, not all of which would be applicable to a cocoa beverage or 
chocolate matrix such as;  
a. Polyphenol structure; cocoa and chocolate predominantly contain catechins and 
proanthocyanidins, although their proportion and quantity is reduced by 
fermentation and other processing procedures (Wollgast and Anklam, 2000). 
Cocoa products tend to have higher levels of the lower molecular weight 
catechins, particularly epicatechin which has been shown to have greater 
bioavailability and stability in comparison to other catechins (Manach et al., 
2005). 
b. Complexity of polyphenol-carbohydrate structure, which in cocoa products, due to 
effects of processing is likely to be less complex than other sources. This can also 
add to the enhanced bioavailability of the polyphenols in the food product 
c. Enzymatic breakdown of the carbohydrate may be a factor that could most 
plausibly contribute to inter-individual variability. Both directly from the 
individual’s expression of enzymes and the effect of the gut microbiota.  
 
Effect of Carbohydrate in the Large Intestine, the Influence of Microbiome.   
The potential beneficial effects of combinations of polyphenols and carbohydrate in the large 
intestine have also been reviewed by Jakobek (2015) suggesting  that the occurance of 
polyphenols in conjunction with carbohydrates can both help the delivery of polyphenols to 
the lower GI tract and provide benefits in the colon itself. The environment of the lower GI 
tract and the increased diversity of enzymes preventable to metabolise polyphenols and 
carbohydrates resistant to digestion, provided by the gut microbiome means this provides an 
additional site where important interactions may take place.  However, unlike in the small 
intestine, unless sugars are conjugated to the flavanol molecule the carbohydrates associated 
with polyphenols in the colon are likely to be more complex having potentially escaped 
hydrolysis.  
 
It has become generally accepted that the gut microbiota is considered to play roles in health 
and disease (Clemente et al., 2012), and can be modulated by certain dietary components, 
especially prebiotics which are non-digestible compounds that are selectively metabolised by 
beneficial microbiota (Bindels et al., 2015). These can include various dietary polyphenols 
(Duenas et al. 2015) and Cocoa flavanols have been proposed as a potential candidate for a 
prebiotic (Strat et al., 2016, Tzounis et al., 2011), exhibiting at least some of their biological 
effects in the colon. In a study by Tzounis et al. (2011), cocoa flavanol intake resulted in 
significantly increased growth of beneficial Bifidobacterium spp. and Lactobacillus spp. in 
human volunteers. It was even postulated that as many of the metabolites observed in plasma 
have been attributed to microbial activity on cocoa polyphenols, owing to the plasma 
compounds not being found in the original cocoa, suggesting the key role of gut microbiota 
in cocoa flavanols activity. Nevertheless, the interactions of cocoa flavanols with 
carbohydrate and sugar in this process is yet to be determined. 
 
The predominant cocoa flavanol monomers, catechin and epicatechin appear to be more 
readily absorbed than more complex polyphenols in the small intestine, although uptake is 
still only around 25-30% of that in the product consumed (Baba et al., 2000). The larger 
molecular weight oligomers (procyanidins) travel undigested to the large intestine, to be 
metabolised by the gut microbiota (Rein et al., 2013, Strat et al., 2016), suggesting molecular 
weight could be a key factor in reaching the lower GI tract. In order for the higher molecular 
weight polyphenols to become bioavailable, it appears that fermentable carbohydrates are 
required. It has been proposed that the fermentation of prebiotic oligosaccharides may 
contribute to the absorption of polyphenols in the large intestine by suppressing bacterial 
degradation of polyphenols in the caecum and stimulating mucosal blood flow (Zhang et al. 
2014). More insight is needed into the role of the lower GI tract in polyphenol metabolism 
and its role in health, especially the potential of a synergistic relationship between 
fermentable carbohydrate, polyphenols and gut microbiota.  
 
The Role of Sugar in Cocoa and Chocolate Products 
Majority of the commercially available products containing cocoa have a high energy 
density; derived from the cocoa butter component (along with some added fats depending on 
the product and the jurisdiction of manufacture) and added sugar. The sugar is added mostly 
for sensory properties, as many of the proposed health promoting bioactives are associated 
with strong bitter flavours and a usually unpleasant mouth feel (Thamke et al., 2009). With 
lower concentrations of the fat free cocoa mass (which are rich in flavanols compared to 
cocoa butter) and more sugar and cocoa butter being associated with a creamy flavour and 
better mouth-feel (Thamke et al., 2009), results in many commercially available products that 
are formulated for flavour containing very modest levels of  these potentially beneficial 
compounds.  
 
One of the relatively unexplored areas is the effects of sugar content in cocoa and chocolate 
products and their influence on the health effects of these commercial products, these have 
been summarised in table 1, and discussed in detail in this review. There appears to be an 
initial thought suggesting that  sugar may reduce the effect of any bioactives, however the 
differences in bioavailability of maybe related to if they are conjugated (glycone) or not 
(aglycone) to a sugar moiety (Bohn, 2014). This, also requires to be moderated by the 
negative effects of excess sugar intake, beyond its calorific load which is its potential to raise 
insulin levels which can mitigate some of the beneficial effects from the flavanols and other 
components, including the depletion of the NO pool which would be enhanced by 
supplementation. 
 
Post-absorption Effects of Sugar on Cocoa Bioactivity  
To date, there is a limited data about the effect of both different sugars on the behaviour of 
cocoa flavanols including bioavailability and overall efficacy in humans. A small number of 
studies have investigated the different effects of sugar sweetened products compared to those 
sweetened with sugar alcohols (Rodriguez-Mateos et al., 2012) on bioavailability along with 
comparing non-nutritive sweeteners (sugar-free) cocoa to sugar sweetened cocoa on 
endothelial function  (Njike et al., 2011, Faridi et al., 2008).  
 
Couple of clinical trials investigated the effects of feeding cocoa products rich in flavanols 
with and without sugar on endothelial function both acutely (Faridi et al., 2008) and then over 
a 6 week period (Njike et al., 2011).  The findings of these studies indicated that flavanol rich 
cocoa improves endothelial function, it appeared that in cocoa given as a beverage the 
addition of sugar resulted in a reduced improvement compared to the non-nutrient sweetener 
beverage. Where the cocoa flavanols were given as an equivalent dose in the form of 
chocolate, the effects appeared to be rather different, suggesting that there could be a 
synergistic interaction between the lipid content of the cocoa butter, flavanols and potentially 
sugar in a solid product.  No statistical analysis was reported comparing the cocoa beverage 
to the chocolate, therefore there is a lack of data to support whether sugar behaves differently 
in cocoa beverages than in solid chocolate. This is definitely an area warranting further study, 
as consuming cocoa flavanols in solid chocolate may lead to better bioavailability (Davison 
and Howe, 2017). Additionally, human studies with variable sugar content are required as the 
optimal sugar content in either a cocoa beverage or chocolate is yet to be determined.  
 
To attempt to explore the difference between beverages and solid chocolate a post hoc t-test 
based on the published data of (Faridi et al., 2008) suggested that for endothelial dysfunction 
there was significantly greater improvement in flow mediated dilation for the dark chocolate 
compared to the sugared cocoa (p=0.0076, standard error of difference (SED) = 0.82) with no 
significant difference between the dark chocolate and the sugar-free cocoa (p=0.1325, SED 
=0.913) (Mellor, 2013). The principle difference between the sugared cocoa and the 
chocolate was that the dark chocolate contained approximately two-thirds less carbohydrate 
(sucrose) than the cocoa (39 compared to 104g). The difference in carbohydrate content, only 
resulted in a 30% reduction in the energy content (327 compared to 460 kcal (1370 compared 
to 1920kJ)); a reflection of the significantly greater fat content of the chocolate (27 compared 
to 2g) for the cocoa (Mellor, 2013). Therefore, it was clear that the cocoa product had far 
more sugar, and it is plausible the excess of sugar could have been the issue with the cocoa 
drink compared to the chocolate, or there could be effects of the combination of sugar 
together with fat in a chocolate matrix. Thus, this limited data could suggest that an optimal 
sugar content may exist for cocoa and chocolate products, that enhances absorption without 
impeding bioactivity. 
 Evidence of the effect of varying the type of sugar, to a sugar alcohol provides data on with 
respect to any beneficial effect of sugar on the absorption of cocoa flavanols. A study by 
Rodriguez-Mateos et al. (2012), aimed to  reduce the energy density and improve the 
glycaemic profile of the product itself. The substitution of sucrose by maltitol, although not 
quite the same as varying the sugar intake gives insight into potential effects, in this case it 
appeared to reduce the absorption of flavanols, which was seen both as area under the curve 
and at with a delay, with significantly less flavanol in plasma at one and two hours following 
ingestion (Rodriguez-Mateos et al., 2012). This finding supports the notion that sugar may 
provide a function in enhancing cocoa flavanols absorption, although there was no 
assessment of bioactivity such as  endothelial function (Njike et al., 2011). 
 
There appears a lack of studies that have attempted to compare chocolate and cocoa which 
has been matched for not only epicatchins and carbohydrate along other potentially 
biologically active compounds (e.g. caffeine and theobromine). To our knowledge, only one 
to date study by  Baba et al. (2000) was identified. This being a very small crossover study 
reporting data from only five healthy males, which, unfortunately was not powered 
adequately to determine a difference in absorption between the cocoa and chocolate. It 
claimed that the only difference between the cocoa and the chocolate was the contribution of 
cocoa butter to the fat and energy content of the chocolate. It could be proposed that there is a 
potential role for both carbohydrate and fat together in enhancing cocoa flavanol absorption. 
This study of the effect of the form of the cocoa product suggested that there were no 
significant differences in uptake from the gut between cocoa and chocolate, although the 
clearance of epicatechin metabolites in the chocolate group was 29.8±5.3% of the ingested 
epicatechins, compared with 25.3±8.1% (p=0.329) for the cocoa. However, the levels of free 
epicatechins appeared to be higher with cocoa at the one and two hour points following 
ingestion (0.10±0.03 compared to 0.22±0.06μmol/l and 0.15±0.04 compared to 0.22±0.02 
μmol/l respectively) (Baba et al., 2000). However, due to its underpowered nature claiming 
no significant effect as it risks a type 1 statistical error.  
 
A logical deduction from the limited data could be that it is suggesting that interactions could 
be occurring in the two different products, which could relate to differences in product 
formulation and composition. This single study presents a mixed picture of the effects of 
cocoa and chocolate on the bioavailability of epicatechin. Based on this study which utilised 
urinary recovery as its measure of bioavailability, was a study with a sample size of 21 would 
have an 80% power to detect a significant difference between chocolate and cocoa at the 0.05 
level estimated using G*Power 3 (Faul et al., 2007). However, this does not directly measure 
bioavailability, along only partially reflecting the retention of epicatechins and their 
metabolites in the body, it does not assess extent and effect of de novo metabolism or the 
activity of metabolites. Therefore, further work is needed to address, including assessments 
of serum epicatechin concentrations, along with data on their metabolites and their biological 
effects. This more forensic approach, is vital to be able to detect any difference in the 
absorption of epicatechins from a macronutrient and other bioactive matched chocolate and 
cocoa. 
 
There are a number of mechanisms to explain why flavanols administered in the form of 
chocolate may have enhanced absorption compared with flavanols administered in a cocoa 
drink. These include a combination of physical and chemical properties of the cocoa or 
chocolate, along with the nutrient and non-nutrient effects on gastrointestinal physiology 
(Mellor, 2013). It is also plausible as most studies are include a comparator, the level of 
participant self-disclosure and adequacy of blinding procedures could influence the study 
outcomes.  
 
A common feature of dietary polyphenols including flavanols, is their need to be hydrolysed 
acidic or enzymatic), as in the plant, they mostly exist in a glycoside form. The length of time 
and amount of hydrochloric acid secreted in the stomach as well as the combination of foods 
ingested will influence the acid hydrolysis. Additionally,  the enzymatic hydrolysis will be 
influenced by the levels of enzymes such as lactase phloridzin hydrolase and cytosolic β-
glucosidase in the intestine (Crozier et al., 2009). Initially, based on data from in vitro 
studies, it was considered that increased time in the stomach might hydrolyse a greater 
proportion of procyanidins and thus increase the pool of epicatechin and other monomeric 
flavanols available for absorption (Spencer et al., 2000). These data were somewhat refuted 
by (Rios et al., 2002) who suggested that in humans fed via a nasogastric tube there were no 
differences seen with respect to degradation of procyanadins after a gastric transit of up to 
60min.   
 
The potential for acid hydrolysis in the stomach of both the glycosides and the procyanadins 
to increase bioavailability of the polyphenols from chocolate or cocoa, could be of 
considerable importance. It has been widely described that stomach emptying is quicker for 
liquids than solids, which could infer that the increased viscosity of chocolate compared to 
cocoa drinks might slow gut transit time. The difference in the fat but not sugar content can 
potentially lead to an increase in the time the food is in the stomach. Gut peptides, including 
cholecystokinin produced by the duodenal mucosa under the influence of fat are known to 
supress gastric emptying (Liddle et al., 1986). This highlights two potential mechanisms on 
how chocolate might act to slow gastric emptying when compared to cocoa. However, to our 
knowledge there is no published work that has tested this.  
 
The product formulation or food matrix also has a number of physical effects that could 
affect bioavailability. A study in much larger molecular weight green tea polyphenol 
epigallocatechin gallate has identified that its systemic absorption was reduced when this 
catechin ingested with food or if it is imbedded in the food matrix if compared to the pure 
product (Naumovski et al., 2015). From the studies reported, the quality and concentrations 
of the cocoa powder constituents used was not always reported including its  ability to be 
dispersed in the medium (typically water)  (Fogliano et al., 2011). Cocoa is not very water 
soluble even in hot water and this property might be a barrier to bioavailability, with the 
hydrophobic cocoa particles being less readily digested, preventing the procyanadins and 
monomeric flavanols from being hydrolysed to more bioavailable forms (Fogliano et al., 
2011). However, in chocolate, these physical characteristics are very different; the cocoa 
tends to be evenly distributed within the product, the effect of which is to increase surface 
area available for hydrolysis and digestion, resulting in increased bioavailability. Therefore, it 
is plausible that the high fat content can provide a hydrophobic matrix, but the particle size is 
likely to be much smaller and as such it is not clear which of these two factors is more 
important in influencing bioavailability. 
 
The effect of food ingredients other than cocoa has to date largely concentrated on the effects 
of adding milk or altering the sugar (usually sucrose) component of the end product. The 
sucrose or other carbohydrate content may be of interest in terms of its biological activity, in 
addition to its potential effects on bioavailability. In human studies, where cocoa was 
administered with or without sugar (sucrose), it appears that sugar might enhance flavanols 
absorption (Schramm et al., 2003).  
 When considering the effect of sugar on bioavailability of cocoa flavanols, it is important to 
consider the potential effects of the form, it appears from post-hoc analysis of data by Faridi 
et al. (2008) reported earlier; that being in the form of chocolate may increase bioavailability 
compared to cocoa and more specifically being associated with greater physiological changes 
following consumption (Davison and Howe, 2017, Davison and Howe, 2015). Although there 
may be a role for sugar in synergy with fat found in chocolate, there could be relationships in 
the differences in delivery and bolus formation in the upper gastrointestinal tract. An 
alternative mechanism could be that a combination of fat and sugar is needed, in that the fat 
may help to alter gastric emptying and protect the flavanols from degradation, and then the 
sugar may facilitate absorption in the small intestine. This view is further supported by the 
earlier observations of (Neilson et al., 2009) which appeared to show an influence, which did 
not reaching significance of sucrose on flavanol absorption.  
 
Reformulation and Potential Future Products 
One of the main problems associated with the available reviewed studies to date is that the 
actual concentrations of included flavanols were not clearly reported and as such the effects 
of flavanols related to the binding with sucrose or fat could not be entirely validated. 
Nevertheless, even at with unknown flavanol concentrations it is evident that a relationship is 
still present and existent. Given the negative health effects associated with the high sugar 
consumption, the use of different sweeteners has clear merits based on preferences and the 
needs of the current food market. However, it appears that these sweeteners can potentially 
reduce flavanol absorption. Therefore, sugar appears to have two roles in chocolate products 
aiming to achieve health benefit, one enhancing uptake and the second masking the bitter 
flavour notes of the flavanols.  
The latter challenge of masking bitter flavours when designing ‘healthy chocolate products’ 
could be addressed perhaps by abandoning the reliance of bitter cocoa flavanols as their 
bioactive. This could take the form of milder tasting white chocolate, with different sources 
of potential bioactives, such as berries, then at the same time as reducing sugar content 
(Morais Ferreira et al. 2016). However, the consumer acceptability and functionality in 
humans of such products is yet to be elucidated.   
 
With the potential scope for many candidate products with different sensory and physical 
characteristics, new approaches to processing and evaluating products will be needed. With 
respect to processing, reducing sugar and other changes in ingredients are likely to alter 
physical properties of chocolate through the various stages of production. This is an area 
warranting further investigation, with adaptations in processing needing to be considered to 
obtain the optimal particle size and viscosity to produce the optimal texture and sensory 
characteristics in the end product (Toker et al., 2017). Alongside adapting processing 
methods, new approaches to sensory evaluation of products during development will be 
required to make this feasible. The use of traditional sensory panels is unlikely to be 
practicalicable when assessing a potential large volume of new formulations prior to pilot 
production. Therefore, novel approaches such as gas chromatography-mass spectrometry 
(Waehrens et al., 2016) could be use to assess candidate products, before taking a feasible 
number of potential products forward to the next stages of product development.  
 
The combinations of different sugar and sweetener concentration ranges need to be definitely 
further investigated as well as the relationships with the fat content. Although it is well 
established that the mouthfeel of food is in general ascribed to the fat content it is important 
to include the different concentrations and potentially different types of fat in the formulation 
of these products, this will have impacts throughout the product development and processing 
stages of any potential product aiming to have health benefits .  
 
REGULATION 
A major challenge of the use of sugar in cocoa and chocolate products is related to the cocoa 
health claims. If cocoa containing food products are to be marketed as health foods and hold 
approved health claims is not limited to just the physiological and food formulation effects. 
Public health policy in some jurisdictions has led to the development of nutrient profiling 
rules for products, linked to their legislative framework for making health claims on foods. 
Perhaps the most clearly articulated of these is perhaps the Food Standards Australia New 
Zealand code, which prior to approving any disease related health related claim a food must 
meet standards regarding levels of other nutrients (FSANZ, 2017). Similar guidance 
developed from the FAO codex exist in European union (EU) and in United States.  These 
systems score products based on factors including energy, fat and sugar content, this could 
discourage a cocoa or chocolate manufacturer from either pursuing a health claim or look at 
ways to improve the nutrient profile, which is likely to have palatability and structural 
impacts on the end product. Ultimately impacting on consumer acceptability, shelf life and 
product cost. 
 
Conclusions and Future Research 
The available data suggests a role for digestible carbohydrate, with sugar or starch in 
enhancing the bioavailability of cocoa flavanols. It is not however clear if this effect is seen 
in both solid chocolate and cocoa beverages. The differences observed between the 
enhancement of absorption and bioactivity seen from solid chocolate compared to cocoa 
drinks could suggest that the effect could be due to a combination of energy dense fat and 
sugar are required to maximise the bioavailability of cocoa flavanols. The data currently 
available is hard to interpret, as there are limited studies and to date they have not reported 
both absorbed metabolites of cocoa flavanols and their biological action.  
 
The potential of a functional need to combine cocoa flavanols with sugar and fat is not an 
ideal solution with respect to overall public health, as the associated excess of energy could 
result in weight gain. Based on the observations of combining cocoa flavanols with bread and 
sucrose (Schramm et al., 2003) and substituting sucrose with maltitol (Rodriguez-Mateos et 
al., 2012) supports the view that optimised flavanol bioavailability appears to occur when 
they are co-consumed with carbohydrate. With respect to bioactivity, the picture is different, 
with artificially sweetened cocoa beverages being more effective than sugar sweetened 
beverages (Njike et al., 2011), although chocolate appeared superior to cocoa beverages. 
What is apparent is that further work is required to gain a further understanding of the ratio of 
flavanols to carbohydrate and the preferred type of carbohydrate to meet the competing needs 
of palatability, enhanced bioavailability and cost. With this in mind, the golden trio of a 
successful functional food; being acceptable to customers, have good bioavailability of the 
active ingredient and functionality of the food product overall will all be achieved. 
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Table 1: Summary of the positive and negative effects of carbohydrate and especially 
sugar on cocoa polyphenol availability and bioactivity. 
 
Site of effect Effect of Sugar/ 
Carbohydrate 
Evidence Reference 
Upper GI Tract 
(small intestine) 
Apparent enhanced 
absorption 
Sugar and carbohydrate 
rich foods appear to 
increase absorption. 
Possibly through 
conjugation of aglycone 
forms of flavanols 
 
Sugar alcohol 
decreases absorption 
relative to sucrose 
Schramm et 
al., 2003 
 
 
 
 
 
Rodriguez-
Mateos et al., 
2012 
Low GI Tract (colon) Interaction between 
the fermentation of 
complex 
polyphenols and 
fermentable 
carbohydrate 
especially 
oligosaccharides 
Potential effect, of the 
oligosaccarhides 
suppressing the 
degradation of 
polyphenols by bacteria 
and stimulating mucosal 
blood flow. This 
synergistic effect may 
have prebiotic potential 
Zhang et al. 
2014 
Post-absorption in vivo 
circulation 
The effect of sugar 
on glycaemia and 
in turn insulin may 
deplete nitric oxide 
(NO) pool.  
 
The synthesis of 
which may have 
been induced by  
epicatechin 
No added sugar 
(artificially sweetened) 
cocoa improved 
endothelial function 
(which is linked to NO 
availability) compared to 
sugar sweetened cocoa 
Njike et al., 
2011,  
Faridi et al., 
2008 
 
